Toru Hashimoto

2.3k total citations
71 papers, 1.8k citations indexed

About

Toru Hashimoto is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Toru Hashimoto has authored 71 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Organic Chemistry, 14 papers in Molecular Biology and 10 papers in Inorganic Chemistry. Recurrent topics in Toru Hashimoto's work include Catalytic Cross-Coupling Reactions (19 papers), Catalytic C–H Functionalization Methods (15 papers) and Organoboron and organosilicon chemistry (9 papers). Toru Hashimoto is often cited by papers focused on Catalytic Cross-Coupling Reactions (19 papers), Catalytic C–H Functionalization Methods (15 papers) and Organoboron and organosilicon chemistry (9 papers). Toru Hashimoto collaborates with scholars based in Japan, United States and United Kingdom. Toru Hashimoto's co-authors include Masaharu Nakamura, Takuji Hatakeyama, Hirofumi Seike, Hikaru Takaya, Tadashi Ishida, Teruo Ono, Y. Fujiwara, Machiko Arita, Makoto Osawa and Isao Ito and has published in prestigious journals such as Science, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Toru Hashimoto

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toru Hashimoto Japan 22 1.1k 322 279 203 116 71 1.8k
Beatríz Garat Uruguay 24 421 0.4× 389 1.2× 542 1.9× 477 2.3× 84 0.7× 59 1.5k
Monika Schmidt Czechia 17 239 0.2× 148 0.5× 164 0.6× 118 0.6× 32 0.3× 50 812
Justin Kim United States 18 1.3k 1.2× 153 0.5× 1.0k 3.8× 85 0.4× 46 0.4× 37 2.5k
Xiaohui Du China 22 332 0.3× 45 0.1× 680 2.4× 218 1.1× 210 1.8× 59 1.7k
Valentina Molteni United States 23 675 0.6× 52 0.2× 663 2.4× 398 2.0× 85 0.7× 36 1.7k
Yaping Han China 26 1.0k 1.0× 201 0.6× 267 1.0× 144 0.7× 41 0.4× 104 1.7k
Ana R. Rodrı́guez United States 23 392 0.4× 43 0.1× 317 1.1× 80 0.4× 42 0.4× 58 1.5k
Anuraag Shrivastav Canada 17 300 0.3× 59 0.2× 569 2.0× 66 0.3× 62 0.5× 48 1.1k
Wenfeng Wang China 21 657 0.6× 181 0.6× 450 1.6× 24 0.1× 93 0.8× 81 1.6k
Hu Wang China 16 143 0.1× 66 0.2× 348 1.2× 78 0.4× 63 0.5× 64 1.0k

Countries citing papers authored by Toru Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Toru Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Hashimoto more than expected).

Fields of papers citing papers by Toru Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Hashimoto. The network helps show where Toru Hashimoto may publish in the future.

Co-authorship network of co-authors of Toru Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Toru Hashimoto. A scholar is included among the top collaborators of Toru Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru Hashimoto. Toru Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yamamoto, Hiroyuki, et al.. (2021). Delayed diagnosis of dilated thyrotoxic cardiomyopathy with coexistent multifocal atrial tachycardia: a case report. BMC Cardiovascular Disorders. 21(1). 124–124. 4 indexed citations
3.
Ito, Akihiro, Tadashi Ishida, Hiromasa Tachibana, et al.. (2017). A Case of Community-Acquired Pneumonia Due to <i>Legionella pneumophila</i> Serogroup 9 Wherein Initial Treatment with Single-Dose Oral Azithromycin Appeared Useful. Japanese Journal of Infectious Diseases. 70(6). 660–662. 6 indexed citations
4.
Hashimoto, Toru, et al.. (2015). Iridium‐Catalyzed [2+2+2] Cycloaddition of α,ω‐Diynes with Cyanamides. Advanced Synthesis & Catalysis. 357(18). 3901–3916. 35 indexed citations
5.
Hashimoto, Toru, et al.. (2014). Iridium-catalyzed [2+2+2] cycloaddition of α,ω-diynes with alkynyl ketones and alkynyl esters. Tetrahedron. 70(45). 8681–8689. 11 indexed citations
6.
Sunada, Yusuke, et al.. (2013). Catalyst design for iron-promoted reductions: an iron disilyl-dicarbonyl complex bearing weakly coordinating η2-(H–Si) moieties. Dalton Transactions. 42(48). 16687–16687. 51 indexed citations
7.
Hatakeyama, Takuji, et al.. (2012). Iron‐Catalyzed Alkyl–Alkyl Suzuki–Miyaura Coupling. Angewandte Chemie International Edition. 51(35). 8834–8837. 158 indexed citations
8.
Matsuura, Hirohide, Toshihiro Ichiki, Xinhua Yin, et al.. (2009). Improvement of neovascularization capacity of bone marrow mononuclear cells from diabetic mice by ex vivo pretreatment with resveratrol. Hypertension Research. 32(7). 542–547. 13 indexed citations
9.
Yamamoto, Yoshihiko, et al.. (2007). Synthesis of Spirocyclic C‐Arylglycosides and ‐Ribosides by Ruthenium‐Catalyzed Cycloaddition. Chemistry - An Asian Journal. 2(11). 1388–1399. 29 indexed citations
10.
Hashimoto, Toru, Naoto Shimizu, Toshinori Kimura, Yoko Takahashi, & Takashi Ide. (2006). Polyunsaturated Fats Attenuate the Dietary Phytol–Induced Increase in Hepatic Fatty Acid Oxidation in Mice. Journal of Nutrition. 136(4). 882–886. 13 indexed citations
11.
Ueno, Shuichi, Ruri Ohki, Toru Hashimoto, et al.. (2003). DNA microarray analysis of in vivo progression mechanism of heart failure. Biochemical and Biophysical Research Communications. 307(4). 771–777. 23 indexed citations
12.
Ito, Isao, Toru Hashimoto, Makoto Osawa, et al.. (2002). Hyper-IgM Syndrome with Systemic Tuberculosis. Scandinavian Journal of Infectious Diseases. 34(4). 305–307. 4 indexed citations
13.
Osawa, Makoto, et al.. (2002). An Autopsied Case of Septicemia due to Vibrio vulnificus. Kansenshogaku zasshi. 76(1). 63–66. 5 indexed citations
14.
Ito, Isao, Tadashi Ishida, Toru Hashimoto, et al.. (2000). Chest Radiograph of Atypical Pneumonia: Comparison among Chlamydia pneumoniae Pneumonia, Ornithosis, and Mycoplasma pneumoniae Pneumonia. Kansenshogaku zasshi. 74(11). 954–960. 5 indexed citations
15.
Ishida, Tadashi, Toru Hashimoto, Machiko Arita, et al.. (1999). Multicenter Screening of Chlamydia pneumoniae Pneumonia by ELISA Method. Kansenshogaku zasshi. 73(1). 70–75. 1 indexed citations
16.
Hashimoto, Toru, et al.. (1997). Long-Term Follow-Up in Treatment of Solar Lentigo and Café-au-Lait Macules with Q-Switched Ruby Laser. Aesthetic Plastic Surgery. 21(6). 445–448. 33 indexed citations
17.
Hashimoto, Toru, Hironobu Nakamura, Shinichi Hori, et al.. (1995). Hepatocellular carcinoma: Efficacy of transcatheter oily chemoembolization in relation to macroscopic and microscopic patterns of tumor growth among 100 patients with partial hepatectomy. CardioVascular and Interventional Radiology. 18(2). 82–86. 28 indexed citations
18.
Motojima, Koichi, et al.. (1992). [Evaluation of immunoreactivity to erbB-2 protein as a marker of prognosis in bile duct carcinoma].. PubMed. 93(9). 952–5. 5 indexed citations
19.
Hashimoto, Toru, Koji Hasegawa, & Akira Kawarada. (1972). Batatasins: New dormancy-inducing substances of yam bulbils. Planta. 108(4). 369–374. 42 indexed citations
20.
Hashimoto, Toru. (1960). Studies on the cytological basis of spore resistance and the origin of the first spore coat.. 7(1). 36–48. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatríz Garat Breakdown of academic impact, for papers by Monika Schmidt Breakdown of academic impact, for papers by Justin Kim Breakdown of academic impact, for papers by Xiaohui Du Breakdown of academic impact, for papers by Valentina Molteni Breakdown of academic impact, for papers by Yaping Han Breakdown of academic impact, for papers by Ana R. Rodrı́guez Breakdown of academic impact, for papers by Anuraag Shrivastav Breakdown of academic impact, for papers by Wenfeng Wang Breakdown of academic impact, for papers by Hu Wang
Rankless by CCL
2026